Immediate Impact

4 from Science/Nature 60 standout
Sub-graph 1 of 24

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Standout
2 intermediate papers

Works of Wolfgang Timmer being referenced

Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis
2019
The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo
2002

Author Peers

Author Last Decade Papers Cites
Wolfgang Timmer 388 447 124 166 29 867
Theodoros Kiropoulos 572 314 85 146 31 1.0k
Evan J. Williams 147 306 94 170 27 765
C. Hardy 297 489 96 76 21 803
Joseph C. Kidney 687 460 47 141 30 1.1k
Sang‐Heon Cho 173 362 125 119 63 1.1k
Alan K. Kamada 378 509 54 67 26 862
Maneesh Bhargava 435 279 113 193 41 916
Sean Jacobson 588 351 40 357 24 1.0k
Teresa Renda 462 249 88 186 20 842
Masahiko Kawakami 184 202 194 261 32 1.1k

All Works

Loading papers...

Rankless by CCL
2026